ArticleBlood advances2021

Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine.

Eleftheria Lamprianidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.